Mendelian Randomization Analysis Reveals Metabolite and Inflammatory Factor Associations with Inflammatory Bowel Disease DOI

Zhaohui Long,

Guang Liu,

Mengying Zhang

et al.

Published: Jan. 1, 2023

This research, drawing from the UK Biobank and encompassing 115,078 participants, harnessed instrumental variables metabolomic quantitative trait loci studies to probe influence of plasma metabolites on Inflammatory Bowel Disease (IBD). High-throughput nuclear magnetic resonance (NMR) was employed non-fasting baseline EDTA samples measure metabolic biomarkers. The study utilized a specific GWAS dataset for IBD identified as ebi-a-GCST90038684, selected 41 inflammatory factors exposure variables. Using conventional genome-wide significance thresholds, SNPs related biomarkers were chosen, statistical tools like linkage disequilibrium (LD) clumping inverse variance weighted (IVW) method applied precise analyses. All evaluations performed R platform using various packages. Notably, Acetone, Glucose, Interleukin-2 receptor antagonist levels demonstrated significant causal relationship with IBD, an OR 1.001 95% CI 1.0004-1.002, p=0.002.

Language: Английский

Pyroptosis: a new insight into intestinal inflammation and cancer DOI Creative Commons

Limin Chao,

Wenjing Zhang,

Yuchao Feng

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Feb. 22, 2024

Pyroptosis is an innate immune response triggered by the activation of inflammasomes various influencing factors, characterized cell destruction. It impacts system and cancer immunotherapy. In recent years, roles pyroptosis in intestinal inflammation have been continuously confirmed. This article reviews latest progress mechanisms, new discoveries inflammasomes, mutual regulation between their applications diseases. Additionally, potential synergistic treatment mechanisms diseases with are summarized, challenges future directions discussed, providing ideas for therapy.

Language: Английский

Citations

10

Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease DOI Creative Commons
Li Yang,

Xiao-meng Li,

Hao-yu Duan

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: May 8, 2024

In the advancement of Inflammatory Bowel Disease (IBD) treatment, existing therapeutic methods exhibit limitations; they do not offer a complete cure for IBD and can trigger adverse side effects. Consequently, exploration novel therapies multifaceted treatment strategies provides patients with broader range options. Within framework IBD, gut microbiota plays pivotal role in disease onset through diverse mechanisms. Bacteriophages, as natural microbial regulators, demonstrate remarkable specificity by accurately identifying eliminating specific pathogens, thus holding promise. Although clinical trials have affirmed safety phage therapy, its efficacy is prone to external influences during storage transport, which may affect infectivity regulatory roles within microbiota. Improving stability precise dosage control bacteriophages—ensuring robustness consistent dosing, targeted delivery infection sites—is crucial. This review thoroughly explores latest developments inherent challenges, focusing on interaction between bacteriophages. It highlights bacteriophages’ potential microbiome modulators offering detailed insights into research bacteriophage encapsulation Particular attention paid functionality various carrier systems, especially regarding their protective properties ability colon-specific delivery. aims provide theoretical foundation using bacteriophages paving way enhanced regulation intestinal

Language: Английский

Citations

6

Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity DOI Creative Commons
Vincenzo Giambra, Danilo Pagliari, Pierluigi Rio

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(22), P. 2654 - 2654

Published: Nov. 19, 2023

Inflammatory bowel diseases (IBDs) are characterized by a persistent low-grade inflammation that leads to an increased risk of colorectal cancer (CRC) development. Several factors implicated in this pathogenetic pathway, such as innate and adaptive immunity, gut microbiota, environment, xenobiotics. At the mucosa level, complex interplay between immune system microbiota occurs; disequilibrium these two alteration permeability, called ‘leaky gut’. Subsequently, activation several inflammatory pathways composition with proliferation pro-inflammatory bacteria, known ‘pathobionts’, take place, leading further increase inflammation. This narrative review provides overview on principal Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs) NOD-like (NLRs), focusing their recognition mechanisms, signaling pathways, contributions responses. We also report genetic polymorphisms TLRs dysregulation NLR can influence regulation contribute development progression disease cancer.

Language: Английский

Citations

15

Biocompatible carbon dots nanozymes as ROS/RNS modulators for ulcerative colitis alleviation by comprehensively orchestrating intestinal homeostasis DOI
Wenjing Wang, Guangrong Lu,

Zhichao Deng

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: unknown, P. 157800 - 157800

Published: Nov. 1, 2024

Language: Английский

Citations

4

Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment DOI

Wei-Qiang Huang,

Tao Jiang, Jiaxuan He

et al.

Probiotics and Antimicrobial Proteins, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 31, 2025

Language: Английский

Citations

0

Cutting-edge insights into the mechanistic understanding of plant-derived exosome-like nanoparticles: Implications for intestinal homeostasis DOI
Xiyuan Liu,

Lihua Mei,

Jiaxin Wang

et al.

Food Research International, Journal Year: 2025, Volume and Issue: unknown, P. 116186 - 116186

Published: March 1, 2025

Language: Английский

Citations

0

Integrated lipid metabolomics and network pharmacology to investigate the potential mechanism of Coix seed in alleviating ulcerative colitis DOI
Zixuan Chen,

Miaomiao Tong,

Jialiang Sun

et al.

Journal of Functional Foods, Journal Year: 2025, Volume and Issue: 127, P. 106744 - 106744

Published: March 28, 2025

Language: Английский

Citations

0

Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies DOI Open Access
Jesús Cosín‐Roger

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(12), P. 6416 - 6416

Published: June 11, 2024

Inflammatory Bowel Disease (IBD) is a complex and challenging health problem that exerts significant impact on the quality of life millions individuals worldwide [...]

Language: Английский

Citations

2

Acupuncture and Moxibustion for Inflammatory Bowel Disease: Regulatory Mechanisms Revealed by Microbiome and Metabolomic Analysis DOI
Xinyue Yang, Min He, Jiazhen Cao

et al.

The American Journal of Chinese Medicine, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 33

Published: Nov. 25, 2024

Acupuncture and moxibustion are widely acknowledged as effective complementary therapies for managing inflammatory bowel disease (IBD) in traditional Chinese medicine. However, the regulatory mechanisms by which these two exert their therapeutic effects IBD yet to be fully elucidated. The objective of this study was investigate action underlying acupuncture regulative differences between them interventions IBD. Using a dextran sodium sulfate-induced mice model, treatments were evaluated examination body weight, stool samples, colon morphology, factors, gut microbiota, metabolites. results indicated that both mitigated weight reduction; improved structural characteristics intestinal tissues; increased levels anti-inflammatory cytokines including interleukin (IL)-10; decreased pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-[Formula: see text]), nuclear factor kappa B (NF-[Formula: text]B), IL-6, IL-1[Formula: text], IL-17. had distinct on regulation microbiota metabolic pathways mice. Moxibustion regulated greater number than acupuncture, majority associated with amino acid metabolism, brain signal transmission, energy pathways. These findings provide scientific basis differential applications clinical practice.

Language: Английский

Citations

1

Enterogenic metabolomics signatures of depression: what are the possibilities for the future DOI
Yangdong Zhang, Xueyi Chen,

Xiaolong Mo

et al.

Expert Review of Proteomics, Journal Year: 2023, Volume and Issue: 20(12), P. 397 - 418

Published: Nov. 7, 2023

Introduction An increasing number of studies indicate that the microbiota-gut-brain axis is an important pathway involved in onset and progression depression. The responses organism (or its microorganisms) to external cues cannot be separated from a key intermediate element: their metabolites.

Language: Английский

Citations

2